Skip to main content

Table 4 The crude and age-specific prevalence of nodding syndrome and other forms of epilepsy in the 2017 survey, in Kitgum, Pader and Moyo districts

From: Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures

 

Kitgum

n = 861

Pader

n = 316

Kitgum & Pader

n = 1177

Moyo

n = 961

P-value

NS and NS plus cases only

 Crude prevalence of NS: %

4.3

5.1

4.5

0

NA

 95% confidence interval of prevalence

3.1–5.9

3.0–8.3

3.4–5.9

0

 

 Age-standardized prevalence rate of NS: %

3.7

4.4

3.8

0

NA

Age-specific prevalence of NS: n (%)

 0–9 years

1 (0.4)

1 (1.0)

2 (0.6)

0

NA

 10–19 years

27 (10.4)

14 (15.7)

41 (11.8)

0

NA

 20–29 years

9 (6.9)

1 (1.6)

10 (5.2)

0

NA

 30–39 years

0

0

0

0

NA

 ≥ 40 years

0

0

0

0

NA

OFE only

 Crude prevalence of OFE: %

5.3

4.1

5.0

4.8

0.831

 95% confidence interval of prevalence

4.0–7.1

2.3–7.1

3.9–6.5

3.6–6.4

 

 Age-standardized prevalence of OFE: %

5.1

3.7

4.5

4.6

0.98

Age-specific prevalence of OFE: n (%)

 0–9 years

2 (0.8)

2 (2.0)

4 (1.1)

9 (3.2)

0.089a

 10–19 years

15 (5.8)

8 (9.0)

23 (6.6)

5 (1.9)

0.005b

 20–29 years

25 (19.1)

2 (3.4)

27 (14.1)

17 (11.1)

0.412b

 30–39 years

1 (1.3)

1 (5.3)

2 (2.1)

4 (4.3)

0.442a

 ≥ 40 years

3 (2.2)

0

3 (1.6)

11 (6.6)

0.026a

All epilepsy cases (NS + OFE)

 Crude epilepsy prevalence: %

9.6

9.2

9.5

4.8

<  0.001

 95% confidence interval of prevalence

7.8–11.9

6.3–13.1

7.9–11.4

3.6–6.4

 

 Age-standardized prevalence rate of epilepsy: %

8.8

7.9

8.3

4.6

<  0.001

  1. IQR Interquartile range, NS Nodding Syndrome only, NS plus Nodding Syndrome and other seizures, OFE Other Forms of Epilepsy, NA Not applicable, CI Confidential interval
  2. aFisher’s exact chi-square test
  3. bPearson chi-square test